Search for: "NOVARTIS AG"
Results 61 - 80
of 440
Sort by Relevance
|
Sort by Date
22 Sep 2020, 2:15 pm
Close followers of the rivalry between the two anti-VEGF agents know that inclusion refers to a newly noted Beovu side effect that practically derailed the drug’s initial launch in age-related macular degeneration (AMD). [read post]
24 Aug 2020, 12:00 am
Finding it difficult to keep up with an ever-changing world in the midst of a health, environmental, social and political crisis, while keeping up with patent law? [read post]
13 Aug 2020, 12:38 pm
On June 25, 2020, the SEC announced settlement with drug company Novartis AG and its subsidiary Alcon Pte Ltd related to payments made by third parties in Asia and Europe to get doctors (including at state-owned hospitals) to prescribe Novartis drugs. [read post]
13 Aug 2020, 7:34 am
One of the newly posted Notices refers to a case where the SEC and Novartis AG (Novartis) settled charges that Novartis violated the Foreign and Corrupt Practices Act (FCPA). [read post]
7 Aug 2020, 12:03 pm
Woman Developed Acute And Severe Loss Of Visual Acuity Following Her Second Beovu Injection (Posted by Tom Lamb at DrugInjuryWatch.com) Beovu (brolucizumab) was approved by the FDA in 2019 for the treatment of neovascular (wet) age-related macular degeneration (AMD). [read post]
3 Aug 2020, 7:02 am
Where there are specialists with a focus on the kind of work with which a patent is concerned, they are the relevant addressees of the patent and their specialist skills are attributed to the notional skilled person, even if the patent might also be of a broader application and of interest to non-specialists (Medimmune Ltd v Novartis Pharmaceuticals UK Ltd [2013] RPC 27). [read post]
28 Jul 2020, 1:00 pm
“To Novartis’ credit, [it] was empowered to function autonomous to Novartis oversight regardless of those findings,” Hahn said. [read post]
17 Jul 2020, 8:57 am
Geneva time (CET)Connect to the meeting via: https://washington.zoom.us/j/94575494401Participants: · Delia Ferreira Rubio, Chair, Transparency International · Klaus Moosmayer, Member of the Executive Committee Novartis, Chief Ethics, Risk and Compliance Officer, Novartis International… [read post]
10 Jul 2020, 7:09 am
Apple’s new patent on spatial audio proves it is serious about the rumored “Apple Glasses” and AR/VR In this week’s featured patents, we cover the latest patent applications from IBM, Intel, Apple, Boston Scientific, Medtronic, Merck, and Novartis. [read post]
2 Jul 2020, 8:41 am
In addition, Novartis AG paid a $112 million fine to the SEC, bringing the total settlement to $345 million. [read post]
1 Jul 2020, 2:02 pm
We begin with this June 9, 2020 news report, "Review committee confirms safety signal of rare adverse events for Beovu", from which we get these insights: Novartis received reports of vasculitis in 14 patients treated for wet age-related macular degeneration with Beovu (brolucizumab-dbll) since its approval by the FDA in October 2019. [read post]
25 Jun 2020, 12:07 pm
Department of Justice (DOJ) announced Novartis AG (“Novartis”), a global pharmaceutical and healthcare company based in Switzerland, agreed to pay over $225 million to resolve FCPA charges for bribery in Greece. [read post]
25 Jun 2020, 10:09 am
The Securities and Exchange Commission today announced that Novartis AG, a global pharmaceutical and healthcare company headquartered in Basel, Switzerland, has agreed to pay over $112 million to settle charges that it violated the books and records and…Read the Full Press ReleaseHave a securities law question? [read post]
17 Jun 2020, 1:15 pm
This FDA regulatory action comes after postmarketing reports of these Beovu vision-loss side effects in 14 patients who received the wet age-related macular degeneration (wet AMD) drug. [read post]
1 Jun 2020, 8:02 am
Pacific REGISTER HERE Join Seyfarth attorneys Dean Fanelli, Dawn Mertineit, and Kate Perrelli, along with in-house counsel Julie McCarthy, General Counsel and Vice-President of Legal Genomics Institute of the Novartis Research Foundation, for a webinar about defining and protecting trade secrets in the pharmaceutical industry. [read post]
22 Mar 2020, 5:42 am
The Delhi High Court passed an order in Novartis Ag & Anr v. [read post]
4 Mar 2020, 1:56 pm
Most of the cases have started after patients’ first or second injection of the wet age-related macular degeneration (AMD) drug, Novartis said. [read post]
27 Feb 2020, 12:40 pm
Beovu injections were approved by the FDA in October 2019 to treat wet age-related macular degeneration, a condition that can eventually lead to blindness. [read post]
13 Feb 2020, 8:16 am
Bloomberg reports that Novartis AG, a Swiss Pharmaceutical firm with a Market Capitalization in excess of 220 billion USD and U.S. headquarters in Boston, is... [read post]
23 Jan 2020, 12:55 pm
Already in the Abraxis (C-443/17) case, AG Mr. [read post]
